check_circleStudy Completed

Dermatitis, Atopic

Study to compare the efficacy and safety of Advantan ointment once daily with Protopic 0.03% ointment twice daily in children and adolescents with atopic dermatitis

Trial purpose

Please see attached Study Results Summary below.

Key Participants Requirements

Sex

Both

Age

2 - 15 Years
  • -

  • -

Trial summary

Enrollment Goal
265
Trial Dates
March 2005 - August 2005
Phase
Phase 4
Could I Receive a placebo
N/A
Products
Advantan (Methylprednisolone Aceponate, BAY86-4862)
Accepts Healthy Volunteer
N/A

Trial design

Double-blind, randomized, reference-controlled, multicenter, parallel-group study to compare the efficacy and safety of Advantan ointment once daily with Protopic 0.03% ointment twice daily over maximum 3 weeks in 250 children and adolescents with atopic dermatitis
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A